By Theodore F. Zipf, Dennis A. Johnston
In Leukemia and Lymphoma: Detection of minimum Residual affliction, hands-on specialists describe and speak about the minimum residual affliction (MRD) equipment they've got effectively pioneered for leukemias and lymphomas. They practice opposite transcription PCR (RT-PCR) to acute myeloid leukemia (AML), power myelogenous leukemia (CML), and acute promyelocytic leukemia (APL). different PCR tools are used for Non-Hodgkin's Lymphoma and for the tracking of follicular lymphoma. extra chapters handle using real-time quantitative PCR (RQ-PCR), the emergent approach to selection, in sufferers with acute lymphoblastic leukemia (ALL), the overview of MRD recommendations in medical trials, and the appliance of stream cytometry thoughts.
Read Online or Download Leukemia and lymphoma : detection of minimal residual disease PDF
Best hematology books
Integrative drugs strives to include the easiest of complementary and standard modalities. This ebook info integrative oncology, a nascent box development a rigorous evidenced-based scientific medication, examine, and academic starting place. It examines 5 prestigious, finished melanoma facilities dependent within the US, overlaying how those facilities began their courses, what they're presently doing, and suggestions for beginning integrative medication clinics.
The effect of hormones on deep venous thrombosis is among the so much charged and debated topics. woman hormonal stability is basically stricken by using both oral contraceptives or HRT. for a very long time it's been well-known that oral contraceptives can bring up the occurrence of DVT; even though, there was a major controversy to whether all progestins do that both or no matter if a few have a better influence than others the place oral birth control is worried.
The booklet is of curiosity to educational and business researchers but in addition clinicians who're engaged on irritation similar subject matters and want to expand their wisdom approximately microarrays and the appliance thereof. After analyzing the booklet a researcher or clinician will be within the place to plot, practice and examine or to severely evaluate microarray experiments on the topic of irritation examine.
- Klinikleitfaden labordiagnostik
- Transplantation in Hematology and Oncology
- Transfusion Immunology and Medicine
- Evidence-Based Hematology
- Aplastic Anemia: Pathophysiology and Treatment
- The Mechanics of the Circulation
Additional resources for Leukemia and lymphoma : detection of minimal residual disease
56. Pui CH and Evans WE. Drug therapy: acute lymphoblastic leukemia, N. Engl. J. , 339 (1998) 605–615. 57. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia, J. Clin. , 14 (1996) 18–24. 58. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, et al. Corticosteroiddependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83), Klin.
Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, and van Dongen JJ. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes, Leukemia, 10 (1996) 1383–1389. 28. Van Lochem EG, Groeneveld K, Te Marvelde JG, Van den Beemd MW, Hooijkaas H, and Van Dongen JJ. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes: testing of a new fixation-permeabilization solution [letter], Leukemia, 11 (1997) 2208–2210.
A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity, Leukemia, 9 (1995) 1233–1239. 14. Sugita K, Mori T, Yokota S, Kuroki M, Koyama TO, Inukai T, et al. The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cells, Leukemia, 13 (1999) 779–785.